Wu Zhen: medicine enterprises shall take judicial measures to deal with IPR disputes

"Enterprises shall fully understand policy environment, take various measures to solve IPR disputes and be courageous to adopt legal weapons," said Wu Zhen, Deputy Director of the State Food and Drug Administration at 2007 Medicine Intellectual Property Forum on October 24.

When enterprises' intellectual property is infringed, obligees can seek administrative protection as well as judicial protection.

Wu said, both protection approaches have advantages as well as disadvantages, e.g. judicial protection is powerful, while procedure is complicated, taking long time and costing much; administrative protection is rapid, but it is usually limited by the administrative responsibilities and is easy waste social public resources and administrative resources.

"At present, IPR adjudication division and collegiate panel have been set up in China's courts and other countries also have judicial IPR protection system to encourage enterprises to solve IPR disputes in judicial approach," Wu said, "as long as you are resolute, confident and have substantial evident, you can win the lawsuit finally." [Chinese version is available on Xinhua]